title: Life-threatening hypothyroidism associated with administration of cyclosporine in a patient treated with reduced-intensity hematopoietic stem-cell transplantation for metastatic renal-cell carcinoma.
authors.affiliation: Hematopoietic Stem Cell Transplant Unit, National Cancer Center Hospital, Tokyo, Japan.
authors.forename: Osamu
authors.initials: O
authors.lastname: Imataki
authors.forename: Sung-Won
authors.initials: SW
authors.lastname: Kim
authors.forename: Rie
authors.initials: R
authors.lastname: Kojima
authors.forename: Akiko
authors.initials: A
authors.lastname: Hori
authors.forename: Tamae
authors.initials: T
authors.lastname: Hamaki
authors.forename: Michiyo
authors.initials: M
authors.lastname: Sakiyama
authors.forename: Naoko
authors.initials: N
authors.lastname: Murashige
authors.forename: Makoto
authors.initials: M
authors.lastname: Satoh
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kami
authors.forename: Atsushi
authors.initials: A
authors.lastname: Makimoto
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Takaue
mesh_terms: D000328:Adult; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000556:secondary / Q000628:therapy*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine